GFAP and Wilson disease: Shribman et al. [23] did not find a significant difference in mean GFAP levels between WD patients (84 ng/L; n = 40) and healthy controls (84 ng/mL; n = 38) or by clinical phenotype (neurological, 84 ng/L; hepatic, 80 ng/L).